Insider Transactions in Q3 2021 at Quanterix Corp (QTRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.27%
|
$240,000
$48.38 P/Share
|
|
Sep 22
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-5.57%
|
$78,349
$47.72 P/Share
|
|
Sep 02
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.27%
|
$245,000
$49.95 P/Share
|
|
Sep 01
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,709
-0.2%
|
$185,450
$50.26 P/Share
|
|
Sep 01
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
353
-0.47%
|
$17,650
$50.26 P/Share
|
|
Sep 01
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
350
-0.52%
|
$17,500
$50.26 P/Share
|
|
Sep 01
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
147
-0.31%
|
$7,350
$50.26 P/Share
|
|
Aug 20
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-5.27%
|
$76,682
$46.13 P/Share
|
|
Aug 17
2021
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
9,954
+9.42%
|
-
|
|
Aug 17
2021
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
310,000
-34.06%
|
-
|
|
Aug 16
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.27%
|
$235,000
$47.62 P/Share
|
|
Aug 10
2021
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
9,952
+10.39%
|
-
|
|
Aug 10
2021
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
310,000
-25.4%
|
-
|
|
Aug 03
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
145
-0.6%
|
$7,685
$53.79 P/Share
|
|
Aug 03
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
346
-0.91%
|
$18,338
$53.79 P/Share
|
|
Aug 03
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
344
-1.01%
|
$18,232
$53.79 P/Share
|
|
Aug 03
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,648
-0.39%
|
$193,344
$53.79 P/Share
|
|
Jul 29
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.27%
|
$270,000
$54.03 P/Share
|
|
Jul 14
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-5.01%
|
$95,019
$57.77 P/Share
|
|
Jul 13
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.26%
|
$285,000
$57.55 P/Share
|
|
Jul 12
2021
|
Michael A Doyle CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
5,530
+50.0%
|
-
|
|
Jul 02
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
146
-0.2%
|
$8,468
$58.46 P/Share
|
|
Jul 02
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
346
-0.34%
|
$20,068
$58.46 P/Share
|
|
Jul 02
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,658
-0.13%
|
$212,164
$58.46 P/Share
|
|
Jul 02
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
347
-0.3%
|
$20,126
$58.46 P/Share
|
|
Jul 01
2021
|
Laurie J Olson |
BUY
Grant, award, or other acquisition
|
Direct |
104
+2.19%
|
$6,136
$59.48 P/Share
|
|
Jul 01
2021
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
231
+1.66%
|
$13,629
$59.48 P/Share
|
|
Jul 01
2021
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
304
+1.99%
|
$17,936
$59.48 P/Share
|
|
Jul 01
2021
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
199
+1.68%
|
$11,741
$59.48 P/Share
|
|
Jul 01
2021
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
218
+0.29%
|
$12,862
$59.48 P/Share
|
|
Jul 01
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
8,454
-9.49%
|
$490,332
$58.49 P/Share
|
|
Jul 01
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
9,806
+17.36%
|
$215,732
$22.12 P/Share
|